Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology/Infectious Diseases | Pediatrics/Neonatology
Clinical Trials: Vaccines
A listing of clinical trials currently looking for volunteers to enroll in Vaccines studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Daphne : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Daphne : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Arizona
Chandler : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Chandler : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Tucson : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Arkansas
Jonesboro : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Jonesboro : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Little Rock : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Little Rock : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
California
Paramount : Center for Clinical Trials, LLC
SHINE Study: We're looking for young adults to volunteer a clinical research study exploring new immunization options for meningococcal diseases like meningitis.
View More »
Cypress : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Fresno : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Hayward : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Huntington Beach : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Huntington Beach : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Loma Linda : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Loma Linda : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Moreno Valley : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Moreno Valley : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Paramount : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Paramount : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Sacramento : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
San Diego : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
San Diego : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Valley Village : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Valley Village : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Colorado
Denver : Radiant Research - Denver
Meningitis Vaccine Research Study
Longmont : Longmont Medical Research Network
Investigational Combination Vaccine Study for Ages 4 through 6
View More »
Colorado Springs : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Colorado Springs : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Denver : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Connecticut
Norwich : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Norwich : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Florida
Miami : Pharmax Research Clinic, Inc.
Flu Vaccine
Tampa : Tampa Clinical Research
Family trip to Asia? Mosquitoes spread the disease Japanese Encephalitis all over Asia. Your child(or the child of someone you know) may be eligible to participate in a research study being conducted by Passport Health and Tampa Clinical Research.
View More »
South Miami : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Tampa : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Georgia
Atlanta : Radiant Research - Atlanta
Meningitis Vaccine Research Study
View More »
Atlanta : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Dalton : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Marietta : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Marietta : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Stockbridge : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Woodstock : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Woodstock : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Idaho
Meridian : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Meridian : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Illinois
DeKalb : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Indiana
Indianapolis : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Kansas
Wichita : Wichita Clinic, PA
Clinical Research Trial studying Rheumatoid Arthritis Therapy and Vaccines
View More »
Augusta : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Wichita : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Wichita : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Kentucky
Bardstown : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Bardstown : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Lexington : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Louisville : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Louisville : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Michigan
Stevensville : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Minnesota
Edina : Radiant Research - Minneapolis
Vaccine Research
View More »
Saint Pail : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Saint Paul : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Saint Paul : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Missouri
St. Louis : Radiant Research - St. Louis
Meningitis Vaccine Research Study
View More »
Kansas City : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Kansas City : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Saint Louis : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
St. Louis : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
St. Louis : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Nebraska
Lincoln : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Lincoln : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Omaha : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Omaha : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Nevada
Henderson : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Henderson : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
New York
Mineola : Winthrop University Hospital Clinical Trials Center
Pediatric Meningococcal Vaccine
Mineola : Winthrop University Hospital Clinical Trials Center
Preventative vaccine
Rochester : Rochester Clinical Research
HPV/Meningitis Vaccine
View More »
East Syracuse : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
East Syracuse : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Rochester : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Syracuse : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Syracuse : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
North Carolina
Raleigh : PMG Research of Raleigh
Attention: Men and Women age 65 years and older are invited to participate in a Flu Vaccine Research Study.
Wilmington : PMG Research of Wilmington
Clostridium Difficile Vaccine: Do You Have An Upcoming Surgery Scheduled?
Wilmington : PMG Research of Wilmington
Research Volunteers Needed
View More »
Cary : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Durham : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Durham : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Raleigh : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Raleigh : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
North Dakota
Fargo : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Fargo : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Ohio
Akron : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Cincinnati : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Cincinnati : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Cleveland : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Cleveland : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
View More »
Columbus : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Huber Heights : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Kettering : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Oklahoma
Norman : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Norman : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Oklahoma City : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Oklahoma City : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Tulsa : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
View More »
Tulsa : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Pennsylvania
Pittsburgh : Primary Physicians Research
A Study for an Investigational Comination Vaccine for Healthy Infants
Pittsburgh : Primary Physicians Research
Adolescents wanted to participate in a clinical trial of an investigational vaccine
Pittsburgh : Primary Physicians Research
Adult Pneumococcal Clinical Research Trial
Pittsburgh : Primary Physicians Research
Ask your doctor about a clinical trial for a new investigational oral vaccine that may protect your baby against rotavirus.
Pittsburgh : Primary Physicians Research
Attention Parents: Your pediatrician is currently conducting a research trial to evaluate investigational combinations of approved childhood vaccines when given together or apart.
Pittsburgh : Primary Physicians Research
Clinical Research trial of an investigational meningococcal vaccine
Pittsburgh : Primary Physicians Research
Healthy infants 7-10 days old
Pittsburgh : Primary Physicians Research
Meningitis Vaccine Research Study for Toddlers
Pittsburgh : Primary Physicians Research
Meningococcal vaccine study
Pittsburgh : Primary Physicians Research
Pneumococcal Conjugate Vaccine 6115A1-004
Pittsburgh : Primary Physicians Research
Primary Physicians Research (PPR) is currently looking to enroll healthy children between the ages of 4 and 7 years old in a clinical research trial of a meningococcal vaccine.
Pittsburgh : Primary Physicians Research
RSV: An important cause of respiratory tract infections in children
PIV3: An important cause of croup. Also contributes to other infections of the respiratory tract
Pittsburgh : Primary Physicians Research
Vaccine Research Needs Your Help
Pittsburgh : Primary Physicians Research
Women wanted to participate in a clinical trial
View More »
Carnegie : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Erie : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Sellersville : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Rhode Island
Cranston : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Cranston : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Warwick : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Warwick : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
South Carolina
Mt Pleasant : Coastal Carolina Research Center
Flu Vaccine Study - Aged 65 years of age or older? Volunteers needed for an investigational flu vaccine research study.
Mt Pleasant : Coastal Carolina Research Center
Pandemic Bird Flu Vaccine Research Study - Healthy Volunteers aged 18 to 64
View More »
Anderson : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Charleston : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Charleston : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Mount Pleasant : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Mount Pleasant : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Tennessee
Bristol : PMG Research of Bristol
Attention: Men and Women age 65 years and older are invited to participate in a Flu Vaccine Research Study.
Bristol : PMG Research of Bristol
Vaccine: Is it time for your child's routine vaccines before starting school?
Nashville : Clinical Research Associates, Inc.
Flu Vaccine
View More »
Bristol : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Nashville : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Nashville : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Texas
Dallas : DallasAllergyImmunologyResearch
Investigational Vaccine Research Study
Houston : DM Clinical Research
An investigational vaccine study that would limit the amount of shots given.
Houston : DM Clinical Research
Pediatric Meningitis Vaccine- Houston,TX
Houston : DM Clinical Research
Pediatric RSV Vaccine- Houston,TX
San Antonio : Lung Diagnostics, LTD
Research study of an investigational vaccine for prevention of Herpes Zoster (Shingles)
San Antonio : Diagnostics Research Group
Research study of an investigational vaccine for prevention of Herpes Zoster (Shingles)
San Antonio : Allergy Diagnostics
Research study of an investigational vaccine for prevention of Herpes Zoster (Shingles)
San Antonio : Women's Diagnostics
Research study of an investigational vaccine for prevention of Herpes Zoster (Shingles)
View More »
Austin : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Dallas : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Houston : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Houston : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
League City : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Richardson : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
San Angelo : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
San Antonio : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
San Antonio : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Tomball : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Tomball : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Utah
Salt Lake City : J. Lewis Research, Inc.
Meningitis Vaccine
South Jordan : J. Lewis Research, Inc.
Meningitis Vaccine
View More »
Murray : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Murray : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Salt Lake City : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Salt Lake City : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
South Jordan : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
West Jordan : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Virginia
Burke : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Charlottesville : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Charlottesville : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Norfolk : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Vienna : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Washington
Vancouver : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Vancouver : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Wisconsin
La Crosse : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Monroe : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Monroe : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
